Skip to main content
    C

    Core Laboratories NV (CLB)

    Official site

    ENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE

    $8.46
    -0.65 (-7.13%)

    Market Cap: $417.45M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Core Laboratories NV (CLB) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Core Laboratories NV (CLB) trades at 15.7x trailing earnings and 0.8x sales. Its P/E of 15.7x is below its 5-year median of 23.2x. Its forward P/E is 19.8x. The median P/E across 8 similar companies is 18.2x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 20.7% lower over the next year.

    MultipleValue
    P/E (trailing)15.7x
    Forward P/E19.8x
    Price to sales0.8x
    Price to book1.4x
    EV/EBITDA9.2x
    PEG1.7
    FCF yield-0.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 46.6% below 29.4x, its P/S is 65.2% below 2.3x and its P/B is 82.5% below 8.0x.

    MultipleCurrent5-year median10-year median
    P/E15.7x23.2x29.4x
    P/S0.8x1.7x2.3x
    P/B1.4x3.7x8.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 19.7x in 2024 to 79.5x in 2016.

    Year endPriceP/EP/SP/B
    2025$16.0321.1x1.4x2.8x
    2024$17.3119.7x1.6x3.3x
    2023$17.6621.8x1.6x3.7x
    2022$20.2734.9x1.9x5.2x
    2021$22.3131.4x2.2x6.7x
    2020$26.5133.6x2.4x16.7x
    2019$37.6721.2x2.5x9.5x
    2018$59.6626.2x3.8x16.5x
    2017$109.5554.8x7.4x32.6x
    2016$120.0479.5x8.8x34.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLB

    What is CLB's forward P/E ratio?

    Core Laboratories NV has a forward P/E ratio of 19.8x.

    Is CLB stock overvalued?

    GNG's valuation label for CLB is Undervalued. Its P/E of 15.7x compares with a median of 18.2x across 8 similar companies.

    What is CLB's price to sales ratio?

    Core Laboratories NV has a price to sales ratio of 0.8x.

    What is Core Laboratories NV's average P/E ratio over 5 years?

    Core Laboratories NV's median P/E over the last 5 years is 23.2x, from 60 month-end values through Oct 2026.

    What is CLB's PEG ratio?

    Core Laboratories NV has a PEG ratio of 1.7.